Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
CrossRef Large-scale screening of HBV epitopes restricted by multiple prevalent HLA-B/C allotypes and routine detection of HBV-specific T cells in CHB patients Yandan Wu, Yu Zhao, Ruixue Ji, Pinqing Li, Huijuan Chen, Fangping Yue, Yi Wu, Jie Qiu, Chuanlai Shen Frontiers in Immunology .2026;[Epub] CrossRef Group-based trajectory modeling for declines in hepatitis B surface antigen over time accurately identifies chronic hepatitis B patients achieving functional cure: a single-center cohort study in China Yuchen Peng, Liping Liu, Xiaoping Wu Annals of Medicine .2026;[Epub] CrossRef Risk Prediction of Hepatocellular Carcinoma After Hepatitis B Surface Antigen Seroclearance in Patients With Chronic Hepatitis B Shuaibing Ying, Jinyao Dai, Qiudan Zhang, Yujing Wang, Yina Yu, Zhijuan Zhang, Shaohua Dong, Yichun Zhang, Haoyang Hu, Yuqi Hong, Yi Liu, Yuqi Guo, Haomin Yan, Yunqing Qiu, Yan Lou Alimentary Pharmacology & Therapeutics .2026
Emergency symptoms warranting 911/ED evaluation include: syncope, seizures, chest pain, severe shortness of breath, or severe confusion
No, patients should not discontinue or replace DMARD therapy with GLP-1 medications
PMID 11204445
US$ 22.74
US$ 27.32
US$ 22.60
US$ 23.45
US$ 28.04
US$ 20.55
US$ 21.28
US$ 28.68
US$ 20.31
US$ 26.41
